Peyton R. Howell - 03 Aug 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role: Director
Signature: s/ David B. Berger, Attorney-in-Fact for Peyton R. Howell
Issuer symbol: TNDM
Transactions as of: 03 Aug 2021
Net transactions value: $0
Form type: 4
Filing time: 05 Aug 2021, 17:57:30 UTC
Previous filing: 20 May 2021
Next filing: 10 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNDM	Common Stock	Options Exercise	$0	+948		$0.000000	948	03 Aug 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNDM	Restricted Stock Unit	Options Exercise	$0	+948	+100%	$0.000000	1,898	03 Aug 2021	Common Stock	948		Direct	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.
F3	This RSU award was granted on August 3, 2020. 33% of the RSU vested on August 3, 2021 and the remaining shares will vest over a period of two years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.
F4	RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 8/3/2021, and the remaining shares shall vest in two (2) equal annual installments thereafter.